A total synthesis of 2-amino-7-(O-D-ribofuranosyl)pyrrolo[2,3-dlpyrimidin-4-one-5-carboxylic acid has been accomplished and confirms the previous structural assignment for the nucleoside antibiotic cadeguomycin.
We now wish to report a total synthesis of the nucleoside 2-amino-7-(B-D-ribofuranosyl)pyrrolo [2,3-dlpyrimidin-4-one-5-carboxylic acid (2, cadeguomycin) .
We initiated two separate routes for the total synthesis of cadeguomycin, with each route being designed to ultimately afford the desired antibiotic. In the first route investigated, we envisaged the use of 2-amino-7-(O-D-ribofuranosyl)pyrrolo [2,3-dl-pyrimidin-4-one-5--carboxamide (4) as the immediate precursor of cadeguomycin. The synthesis of this precursor (4-j was accomplished from the nucleoside antibiotic toyocamycin via a seven step sequence. -However, the low yield (14%) from the last step, treatment of 2-amino-5-cyano-7-(&D- Table I ). 2-amino-7-(S-D-ribofuranosyl)pyrrolo [2,3-dlpyrimidin-4-one-5-carboxylic acid.
However
The synthetic pathway we have developed, vide supra, for the total synthesis of the --nucleoside antibiotic cadeguomycin can now be used to obtain a number of specific analogs of cadeguomycin for more extensive biological and chemotherapeutic evaluations.
